Validation of the in vitro comet assay for DNA cross‑links and altered bases detection
Keywords: 
Comet assay
Cross-links
Oxidized bases
Alkylated bases
Mechanism of action
In vitro
Issue Date: 
2021
Publisher: 
Springer
ISSN: 
1432-0738
Note: 
This article is licensed under a Creative Commons Attribution 4.0 International License
Citation: 
Muruzábal, D. (Damián); Sanz-Serrano, J. (Julen); Sauvaigo, S. (Sylvie); et al. "Validation of the in vitro comet assay for DNA cross‑links and altered bases detection". Archives of Toxicology. 95, 2021, 2825 - 2838
Abstract
Mechanistic toxicology is gaining weight for human health risk assessment. Different mechanistic assays are available, such as the comet assay, which detects DNA damage at the level of individual cells. However, the conventional alkaline version only detects strand breaks and alkali-labile sites. We have validated two modifications of the in vitro assay to generate mechanistic information: (1) use of DNA-repair enzymes (i.e., formamidopyrimidine DNA glycosylase, endonuclease III, human 8-oxoguanine DNA glycosylase I and human alkyladenine DNA glycosylase) for detection of oxidized and alkylated bases as well as (2) a modification for detecting cross-links. Seven genotoxicants with different mechanisms of action (potassium bromate, methyl methanesulfonate, ethyl methanesulfonate, hydrogen peroxide, cisplatin, mitomycin C, and benzo[a]pyrene diol epoxide), as well as a non-genotoxic compound (dimethyl sulfoxide) and a cytotoxic compound (Triton X-100) were tested on TK-6 cells. We were able to detect with high sensitivity and clearly differentiate oxidizing, alkylating and crosslinking agents. These modifications of the comet assay significantly increase its sensitivity and its specificity towards DNA lesions, providing mechanistic information regarding the type of damage.

Files in This Item:
Thumbnail
File
204_2021_Article_3102.pdf
Description
Size
1.1 MB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.